GSE190384 GSE190386 fulvestrant 0 v 8 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE190384_GSE190386_fulvestrant_0_v_8_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE190384_GSE190386_fulvestrant_0_v_8_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE190384_GSE190386_fulvestrant_0_v_8_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE190384_GSE190386_fulvestrant_0_v_8_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

aquaporin 3 (Gill blood group)

Gene

keratin 19

Gene

adhesion molecule with Ig like domain 2

Gene

CD9 molecule

Gene

stearoyl-CoA desaturase

Gene

heat shock protein family A (Hsp70) member 1A

Gene

ISG15 ubiquitin like modifier

Gene

insulin like growth factor binding protein 2

Gene

solute carrier family 38 member 1

Gene

brain abundant membrane attached signal protein 1

  • Gene

    aquaporin 3 (Gill blood group)



  • Gene

    adhesion molecule with Ig like domain 2



  • Gene

    stearoyl-CoA desaturase


  • Gene

    heat shock protein family A (Hsp70) member 1A


  • Gene

    ISG15 ubiquitin like modifier


  • Gene

    insulin like growth factor binding protein 2


  • Gene

    solute carrier family 38 member 1


  • Gene

    brain abundant membrane attached signal protein 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.